Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple belt sensor reliably track stroke recovery?

NCT ID NCT07650331

Knowledge-focused Sponsor: Neuron, Spain Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a wearable sensor (Baiobit®) can reliably measure walking patterns in stroke survivors. Twenty-two adults who had a stroke walked with the sensor on their lower back, and two evaluators compared the results. The goal is to see if this low-cost device can replace expensive lab equipment for routine gait assessment in rehabilitation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Baiobit® wearable inertial sensor
What this could lead to
If successful, this could show that a simple wearable sensor is reliable enough to track walking recovery in stroke rehab, making gait analysis more accessible.
What could go wrong
This is a small, early-stage reliability study with only 24 participants. It does not test treatment effects, and results may not apply to all stroke survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

24 people

The number who actually took part.

Started

Oct 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of a convenience sample of adult stroke survivors receiving outpatient physical therapy and neurorehabilitation care. Participants include individuals with a confirmed diagnosis of either ischemic or hemorrhagic stroke, in both subacute and chronic stages (time since onset greater than one month), who retain the functional capacity to ambulate independently on overground surfaces without physical assistance. All participants are recruited from the outpatient facilities of a specialized neurorehabilitation center (Neuron Clinics) located in Madrid, Spain.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * adults aged 18-85 years * confirmed diagnosis of stroke * ability to ambulate (FAC \> 4), regardless of foot-up use * Capacity to walk 10m without stopping and repeat the trials 6 times across the session * Cognitive ability to understand the study instruction and provide written informed consent Exclusion Criteria: * clinical instability or acute medical conditions that compromise gait safety * concomitant neurological conditions other than stroke * severe musculoskeletal disorders that interfere with gait analysis * balance or coordination impairments secondary to visual or auditory deficits * recent use of substances or medications that impair bait, balance, or postural control * pregnancy * cognitive or behavioral impairments that prevent the proper performance of the test

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Neuron Madrid Río

    Madrid, Madrid, 28045, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.